Article
Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
21 Apr 2021
Abstract excerpt
Objectives Various genomic alterations and genomic signatures, including ERBB2 amplification, mutations in PIK3CA, AKT1, and ESR1, and tumor mutational burden (TMB), have become important biomarkers for treatment selection in breast cancer (BC). This study aimed to investigate the mutational features of Chinese early-stage BC patients. Methods Tumors and matched blood samples collected from 589 Chinese patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
